Jones Day
Client SatisfactionJones Day’s antitrust and competition team leverages its significant agency experience to offer a strong litigation practice, advising major domestic and international corporations and banks across the healthcare, finance, transport, and protein industries on the full range of contentious antitrust issues. Craig Waldman oversees the team from Washington DC, working alongside seasoned litigator John Majoras, a key name for cartel follow-on litigation, large class actions, and merger challenges, and Julie McEvoy, who takes point on putative antitrust class actions in the pharma and protein industries. Also in the key team are David Kiernan, in San Francisco, and Cleveland’s Michelle Fischer; Kiernan is a key contact for clients in the tech and healthcare industries, while Fischer handles class actions in a broad range of industries. Tiffany Lipscomb-Jackson, in Columbus, is a key contact for clients in the petroleum, pharma, and automotive industries and has notable experience handling monopolization allegations, price-fixing cases, and bid-rigging claims. 2023 saw the firm expanding its agency experience with the arrival of Washington DC-based duo Koren Wong-Ervin and Kevin Hart, from the FTC and DOJ, respectively. Another new arrival is Minnesota-based Peter Schwingler, who joined from Stinson LLP in 2023; formerly at the DOJ’s Antitrust Division, Schwingler has a strong track record litigating merger challenges.
Key clients
- Ag Canada and Summerland Varieties Corporation
- American Bankers Association
- Axon Enterprise, Inc.
- Cargill Meat Solutions Corporation
- Cleveland-Cliffs Inc. and AK Steel Holding Corp.
- Emory University
- Google, Inc. and Alphabet Inc.
- Indivior, Inc.
- Marathon Petroleum
- National Beef Packing Company, LLC.
- RE/MAX, LLC
- Sanofi
- SAP SE
- Seaboard Foods LLC
- Sutter Health
- Union Pacific Railway Co.
- Wabtec Corporation
- Wells Fargo, National Association
Work highlights
- Successfully defended Axon in the FTC’s administrative litigation challenging the company’s 2018 acquisition of VieVu. Now defending Axon against follow-on class action claims against the company.
- Successfully defended RE/MAX in nationwide antitrust class action lawsuits brought against a trade association and national real estate franchisors related to commissions paid in millions of residential real estate transactions.
- Representing Sanofi-Aventis U.S. LLC in multiple investigations and lawsuits asserting consumer protection and antitrust claims on behalf of public and private entities alleging that Sanofi and other insulin manufacturers conspired with Pharmacy Benefit Managers (PBMs) to artificially inflate the price of insulin products.
Lawyers
Practice head
The lawyer(s) leading their teams.
Craig Waldman